Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nitric Oxide on Pulmonary Resistances in Tetraplegia
NCT00753948Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ng-nitro-l-arginine methyl ester in tetraplegia, sponsored by VA Office of Research & Development. Started Dec 2006; status: completed.
02
Drugs
ng-nitro-l-arginine methyl ester
03
Conditions
tetraplegia
Beyond the preview
Go deeper on NCT00753948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00753948.